Evaluation of the combination of endothelin receptor antagonists (ERA) and phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension (PAH) in pathologic human pulmonary arteries in an ex-vivo organ bath model

Publication date: February 2021Source: Pulmonary Pharmacology & Therapeutics, Volume 66Author(s): L. Englert, C. Stadlbauer, M. Spaeth, H.S. Hofmann, C. Schneider, R.A. Hatz, G. Preissler, S. Michel, S. Golovchenko, M. Ried, M. Hoenicka
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research